Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 21 January 2000:
Vol. 287. no. 5452, p. 405
DOI: 10.1126/science.287.5452.405b
Prev | Table of Contents | Next

ScienceScope

The Korea-based International Vaccine Institute (IVI) has received a 5-year, $40 million grant from The Bill and Melinda Gates Foundation to introduce vaccines for cholera, dysentery, and typhoid in six Asian countries. The money--for studies on topics such as disease prevalence and better vaccine delivery--is aimed at convincing policy-makers in the developing world that vaccines are a cost-effective way to improve public health.

"While the grant is large, it's small in terms of the job we face," says John Clemens, director of the 3-year-old IVI, which carries out collaborations with U.S. and European researchers and is building labs at Seoul National University. Focusing on Bangladesh, China, India, Indonesia, Thailand, and Vietnam, the money targets diseases that kill nearly 2 million people worldwide every year.

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)